The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

G L Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by G L Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3115041	Crush-Resistant Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion	ETHYPHARM	Jul 25, 2024
EP2653873	Compositions And Uses For Treating Multiple Sclerosis	BIOGEN IDEC MA	Oct 10, 2022
EP3656765	Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol	GRNENTHAL	Apr 15, 2021
EP3199172	Dosing Regimen For Multiple Sclerosis	YEDA RESEARCH	Apr 11, 2019
EP2630962	Low Frequency Glatiramer Acetate Therapy	YEDA RESEARCH	Mar 26, 2019
EP1845956	Break-Resistant Delayed-Release Forms Of Administration	GRNENTHAL	Dec 19, 2017
EP2425821	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	Nov 9, 2017
EP2425824	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	Nov 9, 2017
EP2949335	Low Frequency Glatiramer Acetate Therapy	YEDA RESEARCH	Oct 4, 2017

Discover the latest PTAB cases involving G L Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing G L Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
G L PHARMA	9	-	-	-
EURO CELTIQUE	-	44	-	-
GRNENTHAL	-	22	1	-
YEDA RESEARCH	-	21	-	9